The prevalence of neurologic manifestations of syphilis reported among patients with early- and late-stage disease increased between 2019 and 2022.

Patients with infection-related hospitalization may have increased risk for incident heart failure, including HFrEF and HFpEF.

More than 150 million Americans might lose no-cost access to preventive care services under a case being heard at the US Supreme Court.

Delayed initiation of broad-spectrum gram-negative antibiotic therapy was not linked to worse clinical outcomes among adult inpatients.

A federal team responsible for setting poverty guidelines that determine who qualifies for health and food assistance has been fired.

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

A panel of federal health experts recommended expanded vaccine options for several diseases, including RSV, meningitis, and chikungunya.

Over the past 2 decades, stroke-related mortality among individuals with HIV has decreased, but racial and gender disparities continue to exist.

The likelihood of HCV clearance was increased by participation in Ryan White services among patients with HIV coinfection.

The US FDA announced it is shifting away from animal testing in the development of monoclonal antibody therapies and other drugs.

No association was observed between serious infection risk and Janus kinase inhibitor use in patients with immune-mediated inflammatory skin disease.

The CPS-Ped may be an efficient outcome metric for monitoring disease severity and clinical improvement over time among infants with RSV-related critical illness.